These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 5014036)

  • 1. [New therapeutic technic in diseases of the efferent bile ducts].
    Dierel H
    Wien Med Wochenschr; 1972 Apr; 122(14):187-90. PubMed ID: 5014036
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effectiveness of stachyren in the treatment of patients with chronic cholecystocholangitis].
    Trusov VV; Varfolomeeva TB; Oreshkov TM; Plastinina RA; Sabsaĭ LG
    Vrach Delo; 1972 Nov; 11():66-9. PubMed ID: 4659743
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of the therapeutic effect of pequocrin and allochol in chronic cholecystocholangitis].
    Tsimmerman IaS; Mezheborskiĭ AM
    Vrach Delo; 1976; (5):77-82. PubMed ID: 969428
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of urolesan and phenicarbaran in the combined treatment of chronic cholecystitis].
    Neĭko EM; Skrobach NV
    Vrach Delo; 1985 Jul; (7):13-6. PubMed ID: 4049815
    [No Abstract]   [Full Text] [Related]  

  • 5. [On treatment of cholelithiasis with steinonit].
    Keshisheva AA; Pal'chun MV
    Ter Arkh; 1966 May; 38(5):75-8. PubMed ID: 5991934
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stachyglen treatment of patients with chronic cholecystitis and cholangitis].
    Peleshchuk AP; Kravchenko AI; Pavlenko KA; Polisskiĭ NM; Iampol'skaia BM
    Vrach Delo; 1974 Jan; (1):65-9. PubMed ID: 4468584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with the amphocholeretic drug Odibil in primary and secondary organic as well as functional cholecysto- and cholangiohepathopathies].
    Hunold W
    Z Allgemeinmed; 1975 Feb; 51(5):237-41. PubMed ID: 1093341
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
    Ragimov DM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):518-21. PubMed ID: 5515370
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapeutic effect of Urocholesan in acute and chronic cholecystitis].
    Mamchur FI; Vakaliuk PM; Kekalo LA; Neĭko EM
    Vrach Delo; 1969 Oct; 10():3-5. PubMed ID: 5366812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorder in mechanisms of bile formation and methods of their correction].
    Iakovenko EP; Grigor'ev PIa; Agafonova NA; Iakovenko AV; Prianishnikova AS
    Eksp Klin Gastroenterol; 2003; (6):32-9. PubMed ID: 15065526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of liver diseases in the hands of the general practitioner].
    Blank K
    Z Allgemeinmed; 1969 Apr; 45(11):525-7. PubMed ID: 5785113
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of cholerelics on bile flow in diseases of the liver and of the bile ducts (author's transl)].
    Bode JC; Strohmeyer G
    Leber Magen Darm; 1974 Apr; 4(2):65-71. PubMed ID: 4828906
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholelithin therapy of angiocholecystites and dyskinesias of bile ducts in children].
    Shmorgun SS; Cherniavskaia VG
    Pediatr Akus Ginekol; 1967; 2():27-9. PubMed ID: 5610524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of treatments with the phytopharmaceuticals bilicura and spasmobilicura in disorders of the liver-bile-digestive system].
    Gracza L; Gracza E
    Fortschr Med; 1977 Dec; 95(47-48):2829-31. PubMed ID: 590909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cholagogic agents].
    Pasichnyk IKh
    Farm Zh; 1978; (2):39-43. PubMed ID: 658339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effectiveness of pequocrin in chronic cholecystitis].
    Pocheptsov VG; Khvorostika VN; Rutshteĭn LP
    Vrach Delo; 1976 Oct; (10):60-4. PubMed ID: 1022037
    [No Abstract]   [Full Text] [Related]  

  • 19. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V
    Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058
    [No Abstract]   [Full Text] [Related]  

  • 20. [The chologenic and choleretic action of sorbitol].
    Grancharov V
    Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.